AUTONOMIX MEDICAL, INC. Advertising Expense
AUTONOMIX MEDICAL, INC. (AMIX) reported Advertising Expense of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AdvertisingExpense · last filed 2026-08-13
- AUTONOMIX MEDICAL, INC. advertising expense for the quarter ending 2026-06-30 was $0.00.
- AUTONOMIX MEDICAL, INC. advertising expense for the quarter ending 2026-03-31 was $0.00.
- AUTONOMIX MEDICAL, INC. advertising expense for the quarter ending 2025-12-31 was $0.00.
- AUTONOMIX MEDICAL, INC. advertising expense for the quarter ending 2025-09-30 was $0.00.
- AUTONOMIX MEDICAL, INC. advertising expense for fiscal 2026 was $0.00, a 100.00% decline from fiscal 2025.
- AUTONOMIX MEDICAL, INC. advertising expense for fiscal 2025 was $100.00K, a 94.44% decline from fiscal 2024.
- AUTONOMIX MEDICAL, INC. advertising expense for fiscal 2024 was $1.80M, a 1700.00% increase from fiscal 2023.
- AUTONOMIX MEDICAL, INC. advertising expense for fiscal 2023 was $100.00K.
| Period end | Advertising Expense 3 month | Advertising Expense 6 month | Advertising Expense 9 month | Advertising Expense 12 month | Advertising Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-27 | $0.00 derived: sum of 2 quarters · filed 2026-05-27 | $0.00 derived: sum of 3 quarters · filed 2026-05-27 | $0.00 10-K · filed 2026-05-27 | |
| 2025-12-31 | $0.00 10-Q · filed 2026-02-11 | $0.00 derived: sum of 2 quarters · filed 2026-02-11 | $0.00 10-Q · filed 2026-02-11 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 | $100.00K 10-Q · filed 2025-11-12 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-27 | $0.00 derived: sum of 2 quarters · filed 2026-05-27 | $0.00 derived: sum of 3 quarters · filed 2026-05-27 | $100.00K 10-K · filed 2026-05-27 | |
| 2024-12-31 | $0.00 10-Q · filed 2026-02-11 | $0.00 derived: sum of 2 quarters · filed 2026-02-11 | $100.00K 10-Q · filed 2026-02-11 | $500.00K derived: sum of 4 quarters · filed 2026-02-11 | |
| 2024-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-08 | $100.00K 10-Q · filed 2024-11-08 | $500.00K derived: sum of 3 quarters · filed 2025-08-13 | $1.80M derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-06-30 | $100.00K 10-Q · filed 2025-08-13 | $500.00K derived: sum of 2 quarters · filed 2025-08-13 | $1.80M derived: sum of 3 quarters · filed 2025-08-13 | $1.80M derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29 | $1.70M derived: sum of 2 quarters · filed 2025-05-29 | $1.70M derived: sum of 3 quarters · filed 2025-05-29 | $1.80M 10-K · filed 2025-05-29 | $1.70M 10-K · filed 2024-05-31 |
| 2023-12-31 | $1.30M 10-Q · filed 2025-02-13 | $1.30M derived: sum of 2 quarters · filed 2025-02-13 | $1.40M 10-Q · filed 2025-02-13 | ||
| 2023-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-08 | $100.00K 10-Q · filed 2024-11-08 | |||
| 2023-06-30 | $100.00K 10-Q · filed 2024-08-13 | ||||
| 2023-03-31 | $100.00K 10-K · filed 2024-05-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |